Quick Answer
Viking Therapeutics, Inc. reported Shares Outstanding of 114.79 million shares for fiscal year 2025.
Viking Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 114.79M | +2.9% |
| 2024 | 111.57M | +11.4% |
| 2023 | 100.11M | +27.9% |
| 2022 | 78.26M | +0.0% |
| 2021 | 78.25M | +6.9% |
| 2020 | 73.22M | +1.1% |
| 2019 | 72.41M | +0.9% |
| 2018 | 71.74M | +100.3% |
| 2017 | 35.82M | +72.0% |
| 2016 | 20.82M | +115.0% |
| 2015 | 9.68M | +61.4% |
| 2014 | 6.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 112.45M | +0.9% | +0.1% |
| June 30, 2025 | 112.33M | +1.4% | +0.0% |
| March 31, 2025 | 112.29M | +1.9% | +0.6% |
| December 31, 2024 | 111.57M | +11.4% | +0.1% |
| September 30, 2024 | 111.43M | +11.4% | +0.6% |
| June 30, 2024 | 110.80M | +10.8% | +0.5% |
| March 31, 2024 | 110.23M | +39.0% | +10.1% |
| December 31, 2023 | 100.11M | +27.9% | +0.1% |
- Viking Therapeutics, Inc. showed an increase of +2.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Viking Therapeutics, Inc.’s shares outstanding has grown by 1813.2% (from 6.00 million shares to 114.79 million shares).
- The most recent figure is from Viking Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: